Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Tardive Dyskinesia: Treatment Hierarchy
View through CrossRef
The treatment algorithm for managing tardive dyskinesia (TD) suggests first reducing the dose of the offending agent, followed by VMAT2 inhibitors, and then clonazepam or Ginkgo biloba. Deuterated tetrabenazine requires twice-daily dosing (6 mg BID → up to 48 mg/day), while valbenazine is taken once daily (40 mg → 80 mg). Although anticholinergics are commonly used in clinical practice, they lack strong evidence for treating tardive dyskinesia and cause significant side effects in the elderly.
Title: Tardive Dyskinesia: Treatment Hierarchy
Description:
The treatment algorithm for managing tardive dyskinesia (TD) suggests first reducing the dose of the offending agent, followed by VMAT2 inhibitors, and then clonazepam or Ginkgo biloba.
Deuterated tetrabenazine requires twice-daily dosing (6 mg BID → up to 48 mg/day), while valbenazine is taken once daily (40 mg → 80 mg).
Although anticholinergics are commonly used in clinical practice, they lack strong evidence for treating tardive dyskinesia and cause significant side effects in the elderly.
Related Results
Bereitschaftspotential in tardive dyskinesia
Bereitschaftspotential in tardive dyskinesia
AbstractThe bereitschaftspotential or motor readiness potential is a slow negative electroencephalographic wave occurring 150–1500 ms prior to the onset of a voluntary movement. It...
Elevated Cerebrospinal Fluid Noradrenaline in Tardive Dyskinesia
Elevated Cerebrospinal Fluid Noradrenaline in Tardive Dyskinesia
SummaryCerebrospinal fluid was collected from 28 psychiatric (mostly schizophrenic) inpatients from Bombay, India. These included eight patients with tardive dyskinesia, five with ...
A CROSS-SECTIONAL STUDY OF TARDIVE DYSKINESIA WITH HOSPITALIZED PATIENTS IN THE PERIOD OF SECOND-GENERATION ANTIPSYCHOTIC USE IN A PSYCHIATRIC HOSPITAL IN JAPAN
A CROSS-SECTIONAL STUDY OF TARDIVE DYSKINESIA WITH HOSPITALIZED PATIENTS IN THE PERIOD OF SECOND-GENERATION ANTIPSYCHOTIC USE IN A PSYCHIATRIC HOSPITAL IN JAPAN
Abstract
Background
Tardive dyskinesia (TD) is an iatrogenic movement disorder known as one of the adverse effects of dopamine r...
<b>Association Between Clinically-Assessed Scapular Dyskinesia and Neck Disability and Functional Performance Among Gym-Goers: A Cross-Sectional Study</b>
<b>Association Between Clinically-Assessed Scapular Dyskinesia and Neck Disability and Functional Performance Among Gym-Goers: A Cross-Sectional Study</b>
Background: Scapular dyskinesia is characterized by abnormal scapular movement and impaired neuromuscular control of the scapulothoracic joint. Altered scapular biomechanics can in...
Deanol, Lithium and Placebo in the Treatment of Tardive Dyskinesia
Deanol, Lithium and Placebo in the Treatment of Tardive Dyskinesia
A double-blind crossover study on the effects of deanol and lithium carbonate was conducted on a sample of 29 chronic schizophrenic patients with tardive dyskinesia. In addition to...
Utility of gut-brain electrophysiological coupling in predicting L-Dopa induced dyskinesia in Parkinson’s Disease
Utility of gut-brain electrophysiological coupling in predicting L-Dopa induced dyskinesia in Parkinson’s Disease
Abstract
In this study, we focus on Levodopa induced dyskinesia (LID) condition in Parkinson’s Disease (PD) and investigate the mechanistic role of gut-brain coupli...
SCAPULAR DYSKINESIS AND WORK-RELATED PAIN IN OFFICE WORKERS: A CROSS-SECTIONAL STUDY
SCAPULAR DYSKINESIS AND WORK-RELATED PAIN IN OFFICE WORKERS: A CROSS-SECTIONAL STUDY
Background: Office workers, particularly those working with computers for prolonged hours, were at high risk of developing scapular dyskinesia due to repetitive work and poor postu...
Beyond malaria: A rare case of Tardive dyskinesia-like syndrome in antimalaria therapy
Beyond malaria: A rare case of Tardive dyskinesia-like syndrome in antimalaria therapy
Tardive dyskinesia is an involuntary and iatrogenic hyperkinetic movement disorder triggered by the use of dopamine receptor antagonists or partial agonists. It significantly impac...